Post myocardial infarction Clinical Trials

7 recruitingLast updated: July 25, 2026

There are 7 actively recruiting post myocardial infarction clinical trials across 7 countries. Studies span Not Applicable, Phase 3. Top locations include Amiens, Somme, France, Carnaxide, Lisbon District, Portugal, Cologne, Germany. Updated daily from ClinicalTrials.gov.


Post myocardial infarction Trials at a Glance

7 actively recruiting trials for post myocardial infarction are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Amiens, Carnaxide, and Cologne. Lead sponsors running post myocardial infarction studies include Hospital de Santa Cruz, Portugal, Medical University of Vienna, and Centre Hospitalier Universitaire, Amiens.

Browse post myocardial infarction trials by phase

Treatments under study

About Post myocardial infarction Clinical Trials

Looking for clinical trials for Post myocardial infarction? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Post myocardial infarction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Post myocardial infarction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 3

Ivabradine in the Acute Management of Cardiogenic Shock

Cardiogenic Shock Post Myocardial Infarction
National Institute of Cardiovascular Diseases, Pakistan200 enrolled1 locationNCT07714746
Recruiting

Rapid Microaxial Flow Pump Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock and Persistent Need of Hemodynamic Support

Cardiogenic Shock Post Myocardial Infarction
University Hospital of Cologne115 enrolled1 locationNCT07655479
Recruiting

Cardiovascular Outcomes Registry in Cardiogenic SHOCK (COR-SHOCK)

Cardiogenic ShockCardiogenic Shock AcuteCardiogenic Shock Post Myocardial Infarction
Hospital de Santa Cruz, Portugal800 enrolled1 locationNCT07597291
Recruiting

OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science

Cardiogenic ShockMechanical Circulatory SupportCardiogenic Shock Post Myocardial Infarction
Medical University of Vienna100 enrolled1 locationNCT07619144
Recruiting

Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock

Septic ShockMyocardial Infarction (MI)Mechanical Circulatory Support+3 more
Centre Hospitalier Universitaire, Amiens2,500 enrolled1 locationNCT07354568
Recruiting
Not Applicable

Early Beta Blocker Administration in STEMI Patients With SCAI B Status

ST-segment elevation myocardial infarction (STEMI)Cardiogenic Shock Post Myocardial Infarction
Tel-Aviv Sourasky Medical Center200 enrolled1 locationNCT06967194
Recruiting

Effects of Personalised Exercise Rehabilitation FOR people with Multimorbidity and cardiac or pulmonary disease: the PERFORM-CPR trial.

Post myocardial infarctionPost cardiac revascularizationCancer+3 more
Monash University604 enrolled8 locationsACTRN12624001191583